Episode 383: A Neoantigen Vaccine Generates Anti-Tumor Immunity in RCC

David Braun, MD, PhD joins the show to discuss his Nature paper on a personalized RCC vaccine that demonstrated antitumor immunity and delayed recurrence. Dr. Braun is a physician/scientist at Yale Cancer Center and Yale School of Medicine.